Stay updated on Cardiol Therapeutics Press Releases
Sign up to get notified when there's something new on the Cardiol Therapeutics Press Releases page.

Latest updates to the Cardiol Therapeutics Press Releases page
- ChecktodayChange DetectedCardiol Therapeutics’ displayed share prices changed from $1.71 to $1.41 on NASDAQ and from $2.43 to $2.03 on the TSX.SummaryDifference0.4%

- Check7 days agoChange DetectedStock prices were updated to $1.71 and $2.43. A new September 23, 2026 MAVERIC enrollment press release was added to the Press Releases list, while the May 14, 2026 conference item and its related content were removed.SummaryDifference1%

- Check14 days agoChange DetectedAdded new stock price values ($1.875, $2.61), the September 16, 2026 date, and a new press release title Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds to the Press Releases page. Removed older stock prices ($1.995, $2.75), the May 7, 2026 date, and Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association.SummaryDifference1%

- Check21 days agoChange DetectedThe Press Releases page now shows updated stock quotes in the header ($1.995 and $2.75), and adds entries for the US$150 million shelf prospectus filing and two upcoming investor conferences on Sept 9–10, 2026. It also removes several MAVERIC-related press releases from April 2026.SummaryDifference4%

- Check28 days agoChange DetectedDifference0.4%

- Check36 days agoChange DetectedStock price figures on the investor page were updated. The previous values of $1.86 and $2.58 were replaced with $1.94 and $2.70.SummaryDifference0.4%

Stay in the know with updates to Cardiol Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Cardiol Therapeutics Press Releases page.